Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $2.60M.
ENTERPRISE VALUE (EV)
$2.60M
Ensysce Biosciences, Inc.
Market Cap
$6.61M
Enterprise Value (EV)
$2.60M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Ensysce Biosciences, Inc. (ENSC) | $6.61M | $2.60M |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.57M | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.54M | $7.11M |
| Aclarion, Inc. (ACON)vs › | $6.72M | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | $15.51M |
| Exicure, Inc. (XCUR)vs › | $6.82M | $5.10M |
| Femasys Inc. (FEMY)vs › | $6.22M | $9.57M |
| Co-Diagnostics, Inc. (CODX)vs › | $7.00M | $5.15M |
| KALA BIO, Inc. (KALA)vs › | $7.06M | $6.83M |
| Mangoceuticals, Inc. (MGRX)vs › | $7.07M | $7.16M |
Market Cap
$6.61M
Total Debt
$306708.00
Cash
$4.31M
Enterprise Value
$2.60M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
